Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
08/2009
08/13/2009US20090203710 Novel piperidine derivative
08/13/2009US20090203696 Aryl- and Heteroaryl-Ethyl-Acylguanidine Derivatives, Their Preparation and Their Application in Therapeutics
08/13/2009US20090203663 Chemical compounds
08/13/2009US20090202725 Water compatible sterically hindered alkoxyamines and hydroxy substituted alkoxyamines
08/13/2009US20090199351 Water compatible sterically hindered alkoxyamines and hydroxy substituted alkoxyamines
08/13/2009CA2713855A1 Benzylpiperizine compound
08/13/2009CA2711399A1 3-substituted sulfonylpiperidine derivative
08/12/2009EP2086935A1 Substituted sulfonamide derivatives for use as bradykinin 1 receptor modulators
08/12/2009EP2086934A2 Water tolerant emulsion stabilizers
08/12/2009EP2086327A1 Enantiomer-enriched alpha-,omega amino alcohol derivatives, their production and use as insect- and mite-repelling agents
08/12/2009EP1461384B1 Novel flame retarding compounds
08/12/2009EP1429771B1 Bicyclic compounds as inhibitors of chemokine binding to us28
08/12/2009EP1343760B1 Muscarinic antagonists
08/12/2009EP1077941B1 Compounds with growth hormone releasing properties
08/12/2009CN101506165A Phenyl, pyridine and quinoline derivatives
08/12/2009CN101506164A Piperidine derivatives
08/12/2009CN101503392A Aromatic aminomethane compounds, as well as preparation and medical use thereof
08/11/2009US7572918 Process for preparing substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds
08/11/2009US7572913 Inhibitors of Rho kinase; N-Benzyloxycarbonyl-4-[N''-(tert-butyloxycarbonyl)hydrazino]piperidine; 4-{[N''-(tert-butyloxycarbonyl)-N'-(1'-propyl)]hydrazino}piperidine
08/11/2009US7572869 7.9 diethyl-6,7,9-trimethyl-8-(1-phenyl-ethoxy)-1,4-dioxa-8-aza-spiro[4.5]decane initiator for polymerizing ethylenically unsaturated monomer(s); low polydispersity
08/11/2009US7572817 Carboxypeptidase U inhibitors; thrombosis, atherosclerosis, adhesions, dermal scarring, cancer, fibrotic conditions, inflammatory diseases; e.g. 2-[(6-Aminopyridin-3-yl)methyl]-3-mercapto-5-[3-(pyrrolidin-1-ylcarbonyl)phenyl]pentanoic acid
08/11/2009US7572814 Useful in causing mitotic arrest and cell death; (cis,trans)-1-cyclopentyl-4-phenyl-5-(phenylcarbonyl)(3-piperidyl)phenyl ketone
08/11/2009US7572813 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; N-[2-[[(cis) -2-[[1- (4-Chlorophenyl)ethyl]amino]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide
08/11/2009US7572811 Immunosuppressant compounds and compositions
08/11/2009US7572794 Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
08/11/2009US7572787 Substituted naphthalene sulfonamides
08/11/2009US7572786 Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
08/11/2009CA2546660C Selective inhibitors of viral or bacterial neuraminidase
08/11/2009CA2174060C Inhibition of unsaturated monomers with 7-aryl quinone methides
08/06/2009WO2009096526A1 Carboxylic acid compound or salt thereof
08/06/2009WO2009096198A1 Novel biaryl derivative
08/06/2009WO2008103354A3 Modulators of acetyl-coenzyme a carboxylase and methods of use thereof
08/06/2009US20090198065 Resist polymer, resist composition, process for pattern formation, and starting compounds for production of the resist polymer
08/06/2009US20090198052 Method for preparing optically active piperidine compounds
08/06/2009US20090198033 Novel Alkoxyamines Containing Unsaturated Groups
08/06/2009US20090197918 Pesticide benzyloxy- and phenetyl-substituted phenyl-amidine derivatives
08/06/2009US20090197914 Piperidine Derivatives, Their Process for Preparation, Their Use as Therapeutic Agents and Pharmaceutical Compositions Containing Them
08/06/2009US20090197844 Demethylpenclomedine Analogs and Their Use as Anti-Cancer Agents
08/06/2009US20090197201 Fluorosurfactants
08/06/2009DE102008040045A1 Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethylpiperidin Process for the preparation of 4-amino-2,2,6,6-tetramethylpiperidine
08/05/2009EP2085391A2 Inhibitors of factor XA and other serine proteases involved in the coagulation cascade
08/05/2009EP2085385A1 Method of manufacturing 4-Amino-2,2,6,6-tetramethylpiperidin
08/05/2009EP2085384A1 Method of manufacturing 4-Amino-2,2,6,6-tetramethylpiperidin
08/05/2009EP2085383A1 Piperidine derivatives or salts thereof
08/05/2009EP2085379A1 Arylsulfonamido-substituted hydroxamic acid derivatives
08/05/2009EP2083816A2 Heterocyclic amide compounds useful as kinase inhibitors
08/05/2009EP2083624A2 2-hydroxy-2-phenyl/thiophenyl propionamides as androgen receptor modulators
08/05/2009EP1753721B1 Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems
08/05/2009EP1742707A4 Treatment of cns disorders using cns target modulators
08/05/2009EP1461313B1 Human adam-10 inhibitors
08/05/2009EP1383731B1 Biaryl compounds as serine protease inhibitors
08/05/2009EP1249233B9 Npyy5 antagonists
08/05/2009CN101501043A Amido-organoborate initiator systems
08/05/2009CN101500997A PARP inhibitors
08/05/2009CN101500568A Pharmaceutical formulations of pimavanserin
08/05/2009CN101497583A Process for the preparation of 4-amino-2,2,6,6-tetramethylpiperidine
08/05/2009CN101497582A N-substituted-1-deoxynojirimycin compound and preparation thereof
08/05/2009CN101497581A Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
08/05/2009CN100522976C Novel azacyclic ethynyl derivatives
08/05/2009CN100522921C Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof
08/04/2009US7569601 Such as (2E)-3-{4-[1-ethyl-2,2-bis(4-hydroxyphenyl)ethenyl]phenyl}-2-propenoic acid; for selective estrogen receptor modulation; menopausal or postmenopausal disorders, vasomotor symptoms, urogenital or vulvar vaginal atrophy, atrophic vaginitis, female sexual dysfunction, breast cancer, osteoporosis
08/04/2009US7569588 Biphenyl compounds useful as muscarinic receptor antagonists
08/04/2009US7569587 Such as 14-O[(N-(3-Methyl-2-amino-buturyl-piperidin-3(S)-yl)sulfanyl)acetyl]mutilin
08/04/2009US7569585 Drugs; analgesics; anesthetics; antiarrhythmia agents; antiinflammatory agents ; incontinence; gastrointestinal disorders; neurodegenerative disease
08/04/2009US7569579 for inhibition of HIV replication and treatment of acquired immune deficiency syndrome
08/04/2009US7569079 Hair affinity; light and shampooing fastness; such as 1-(6-{3-[4-(1H-imidazol-1-yl)butyl]-1H-imidazol-3-ium-1-yl}hexyl)-4-{[methyl(phenyl)hydrazono]methyl}quinolinium dibromide; multicompartment cosmetic kits
07/2009
07/30/2009WO2009092642A1 Sulfonamides as orexin antagonists
07/30/2009WO2008103613A3 Hydroxylamine compounds and methods of their use
07/30/2009US20090192194 Cyclic Amine Derivatives, Processes For Their Preparation, And Pharmaceutical Compositions Containing Them
07/30/2009US20090192192 Inhibitors of biofilm formation of gram-positive and gram-negative bacteria
07/30/2009US20090192136 Benzoyl-piperazine derivatives
07/30/2009US20090191125 Diagnostic and Therapeutic Alkyl Piperidine/Piperazine Compounds and Process
07/30/2009CA2709050A1 Sulfonamides as orexin antagonists
07/29/2009EP2081899A2 Alternate process for remifentanil preparation
07/29/2009EP2081898A2 Adamantylurea compounds as soluble epoxide hydrolase inhibitors
07/29/2009EP1773339A4 Crystalline form of donepezil hydrochloride
07/29/2009EP1363876B1 Glucocorticoid receptor modulators
07/29/2009CN101495451A (S)-(-)-amlodipine camsylate or hydrate thereof and pharmaceutical composition comprising same
07/29/2009CN100519573C Novel chemical substance having morphogenetic and growth-accelerating activities
07/29/2009CN100519528C Compounds with analgesic effect
07/29/2009CN100519527C Inhibitors of histone deacetylase
07/28/2009US7566706 Drug delivery methods of 17-ammonium hydroquinone ansamycin analogs with improved solubility and air stability; antiproliferative and anticarcinogenic agents
07/23/2009WO2009090320A1 Method for preparing disubstituted piperidine and intermediates
07/23/2009WO2009090173A1 Novel piperidine-4-carboxylic acid phenyl-alkyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
07/23/2009WO2009089842A1 Process for producing pipecolic-2-acid-2 ',6'-xylidide useful as an intermediate for the preparation of local anesthetics
07/23/2009WO2009089841A1 Process for the preparation of (s)-1-alkyl-2',6'-pipecoloxylidide compound
07/23/2009WO2009071678A3 Morpholine derivatives as antiobesity agents
07/23/2009WO2009043747A3 N-heterocyclic biaryl carboxamides as ccr receptor antagonists
07/23/2009WO2008087421A3 Male contraceptive
07/23/2009US20090187025 Pharmaceutical composition for promoting angiogenesis
07/23/2009US20090187024 Ropivacaine hydrochloride anhydrate and the preparation thereof
07/23/2009US20090187021 Indane compounds as ccr5 antagonists
07/23/2009US20090187020 Process And Intermediate For Preparation Of Donepezil
07/23/2009US20090186921 Azacyclic compounds
07/23/2009US20090186920 Sulfonamides as orexin antagonists
07/23/2009US20090186919 Piperidine derivatives for treatment of alzheimer's disease
07/23/2009US20090186884 such as N-(3-amino-2-hydroxypropyl)-3-(1-(2-(2-ethylphenoxy)phenyl)-1-hydroxy-5-;methoxypentyl)piperidine-1-carboxamide, used for the treatment of cardiovascular disorders
07/23/2009US20090186874 Carboxamide derivative and use thereof
07/23/2009US20090186871 Tyrosine kinase inhibitors
07/23/2009US20090186862 Treatment of cystic fibrosis
1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 380